Publicaciones destacadas

Prognostic value of Factor VIII, D-Dimer and High Molecular Risk variants assessing re-thrombosis risk in non-cirrhotic portal vein thrombosis☆

Baiges, Anna; Procopet, Bogdan; Téllez, Luis; Llop, Elba; Darnell, Anna;

(...)

Calleja Panero, José Luis; Bureau, Christophe; Albillos, Agustín; Hernández-Gea, Virginia; García-Pagán, Juan Carlos.

Referencia:
JHEP Reports 2026.
Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

Puente, Angela; Turon, Fanny; Martinez, Javier; Fortea, Jose Ignacio; Guerra, Manuel Hernandez;

(...)

Villanueva, Candid; Gonzalez-Alayon, Carlos; Albillos, Agustin; Crespo, Javier; Garcia-Pagan, Juan Carlos.

Referencia:
JOURNAL OF HEPATOLOGY 2025.
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosis

Anton, Aina; Shalaby, Sarah; Botero, Maria Luisa; Blasi, Annabel; Fundora, Yiliam;

(...)

Argemi, Josepmaria; Friedman, Scott L; Garcia-Pagan, Juan Carles; Camprecios, Genis; Hernandez-Gea, Virginia.

Referencia:
HEPATOLOGY 2025.
Isolation and immortalization of human portal vein endothelial cells: A novel research tool for studying splanchnic vasculature

Anton, A; Shalaby, S; Campalans, J; Blasi, A; Fundora, Y;

(...)

Argemi, J; Tura-Ceide, O; Garcia-Pagán, JC; Campreciós, G; Hernández-Gea, V.

Referencia:
JHEP Rep 2025.
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.

Magaz M; Giudicelli-Lett H; Abraldes JG; Nicoară-Farcău O; Turon F;

(...)

Nevens F; Hernández-Gea V; Tripathi D; Rautou PE; García-Pagán JC;.

Referencia:
JOURNAL OF HEPATOLOGY 2025.
Bilirubin Removal with Therapeutic Plasma Exchange or Molecular Adsorbent Recirculating System as Treatment for Cholemic Nephropathy in Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Case Series

Jimenez-Esquivel, Natalia; Pineiro, Gaston; Carpio, Adria; Ortiz, Oswaldo; Lozano, Miquel;

(...)

Sanz, Miquel; Charry, Paola; Poch, Esteban; Fernandez, Javier; Reverter, Enric.

Referencia:
BLOOD PURIFICATION 2025.
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Perez-Campuzano, V; Rautou, PE; Marjot, T; Praktiknjo, M; Alvarado-Tapias, E;

(...)

Wiesch, JSZ; García-Pagán, JC; Barnes, E; Plessier, A; Hernández-Gea, V.

Referencia:
JHEP Rep 2024.
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

Elkrief, L; Hernandez-Gea, V; Senzolo, M; Albillos, A; Baiges, A;

(...)

Toso, C; Tripathi, D; Valla, D; Ronot, M; Rautou, PE.

Referencia:
Lancet Gastroenterology & Hepatology 2024.
Primary Budd-Chiari Syndrome

Garcia-Pagán, JC; Valla, DC;

Referencia:
NEW ENGLAND JOURNAL OF MEDICINE 2023.
Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis

Baiges, A; Procopet, B; Silva, G Jr; Llop, E; Tellez, L;

(...)

Reverter, JC; Bureau, C; Bosch, J; Hernández-Gea, V; Garcia-Pagán, JC.

Referencia:
JOURNAL OF HEPATOLOGY 2023.